Reiferon retard (pegylated hansenula-derived recombinant interferon alpha 2a)
/ MinaPharm, Dynavax
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 14, 2013
Trial comparing the efficacy, tolerability and safety between three arms in treatment of HCV in Egyptian population (Quadritherapy)
(clinicaltrials.gov)
- P4, N=300; Sponsor: MinaPharm; Recruiting; New P4 trial.
New P4 trial • Hepatitis C Virus
1 to 1
Of
1
Go to page
1